Cartesian Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.54

+0.12 (+1.43%)

As of May 16, 2:07 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +376.1% upside

Low Target $22.44

Average Target $40.66

High Target $45.57

Current Price $8.54

Current
$8.54

Target
$40.66

$22.44 $40.66 avg $45.57

Scenario Analysis

Bear Case

$22.44

162.8%

Low target

Base Case

$40.66

+376.1%

Avg target

Bull Case

$45.57

+433.6%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$15.57

-45.2% from high

52-Week Low

$5.60

+52.5% from low

Target vs 52W High

$40.66

+161.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%